Point72 Asset Management, L.P. 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:56 am Sale | 2023-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Point72 Asset Management, L.P. | 822,334 3.000% | -743,495 (-47.48%) | Filing |
| 2023-10-05 4:47 pm Purchase | 2023-10-04 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Point72 Asset Management, L.P. | 1,565,829 5.600% | 1,565,829 (New Position) | Filing |